New York State Common Retirement Fund Theseus Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$2.12 - $4.18 $89 - $175	-42 Reduced 0.44%	9,564 $39,000
Q3 2023 Nov 07, 2023	BUY	$2.66 - $10.04 $191 - $722	72 Added 0.76%	9,606 $26,000
Q2 2023 Aug 07, 2023	SELL	$7.28 - $11.82 $131 - $212	-18 Reduced 0.19%	9,534 $89,000
Q1 2023 May 02, 2023	BUY	$5.21 - $14.05 $5 - $14	1 Added 0.01%	9,552 $85,000
Q3 2022 Nov 08, 2022	BUY	$5.7 - $8.68 $319 - $486	56 Added 0.59%	9,551 $55,000
Q1 2022 May 05, 2022	BUY	$8.75 - $14.51 $68,635 - $113,816	7,844 Added 475.11%	9,495 $109,000
Q4 2021 Feb 02, 2022	BUY	$8.98 - $20.09 $14,825 - $33,168	1,651 New	1,651 $21,000

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.